Cytokeratin 13 anticorps (full length)
Aperçu rapide pour Cytokeratin 13 anticorps (full length) (ABIN7878479)
Antigène
Voir toutes Cytokeratin 13 (KRT13) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- full length
-
Fonction
- Cytokeratin 13 Antibody / KRT13
-
Purification
- Protein G affinity chromatography
-
Immunogène
- A recombinant full-length human KRT13 protein was used as the immunogen for this Cytokeratin 13 antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the Cytokeratin 13 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store the Cytokeratin 13 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))
-
Autre désignation
- Cytokeratin 13
-
Sujet
- Cytokeratin 13 (KRT13) is the major acidic keratin, which together with KRT4, its basic partner, is expressed in the suprabasal layers of non-cornified stratified epithelia including tongue mucosa, esophagus, anal canal epithelium, tracheal epithelium, uterine cervix, and urothelium. Defects in the KRT13 gene are a cause of white sponge nevus of cannon (WSN), a rare autosomal dominant disorder, which predominantly affects non-cornified stratified squamous epithelia and is characterized by the presence of soft, white and spongy plaques in the oral mucosa. KRT13 has been used as a marker for non-keratinized squamous epithelium. It is also expressed in various squamous metaplasia, but it is down regulated in squamous dysplasia and squamous carcinoma.
-
UniProt
- P13646
Antigène
-